Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea - Concepedia

Concepedia

Publication | Closed Access

Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea

222

Citations

37

References

2007

Year

J.Q. Del Rosso, Guy Webster, Mark Jackson, Marta I. Rendon, Phoebe Rich, Helen Torok, Mark Bradshaw

Journal of the American Academy of Dermatology

InflammationAnti-inflammatoryClinical TherapeuticPharmacologyClinical TrialsAnti-inflammatory Dose DoxycyclineSkin PharmacologyPharmacotherapy40-Mg DoxycyclineMedicine

References

	Year	Citations

Page 1